Analytical Data
-
Gene name
UL99
- Application
-
Alternative Names
28KDA structural phosphoprotein pp28
-
Species
Human cytomegalovirus
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P13200
-
Expression Region
2-190aa
-
Molecular Weight
24.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UL99, also known as the UL99 protein of human cytomegalovirus (HCMV), is a key component in the virus's ability to replicate and spread within the host. HCMV is a member of the herpesvirus family and is a significant public health concern, particularly for immunocompromised individuals and organ transplant recipients. The UL99 protein is involved in several critical processes, including the formation of the viral tegument and the assembly of viral particles. Research into UL99 has gained importance as scientists aim to understand its role in the viral life cycle and its interaction with host cellular mechanisms. By characterizing UL99, researchers seek to identify potential targets for antiviral therapies, especially in the context of rising resistance to existing antiviral drugs. The ability to produce recombinant UL99 protein has facilitated detailed studies on its structure and function, allowing for insights into its role in HCMV pathogenesis. Increased understanding of UL99 may pave the way for novel therapeutic strategies that can hinder HCMV replication and improve outcomes for affected patients. As HCMV infections remain a leading cause of morbidity in susceptible populations, ongoing investigations into the biology of UL99 are crucial in the fight against this pervasive virus.
